Santhera Pharmaceuticals Holding AG, at its AGM held on June 27, 2023, announced the appointment of Bradley C. Meyer and Otto Schwarz, PhD, members of the Board of Directors, also for a term of one year. In addition, shareholders elected Thomas Meier, PhD, as Chairman of the Board of Directors. As members of the Compensation Committee, the shareholders confirmed Thomas Meier, PhD, and elected Bradley C. Meyer (Committee Chairman).

Patrick Vink, member of Santhera’s Board and Chairman of the Compensation Committee since 2017, decided not to stand for re-election.